Business Description
Biotech Growth Trust (The) PLC
ISIN : GB0000385517
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.05 | |||||
Equity-to-Asset | 0.88 | |||||
Debt-to-Equity | 0.13 | |||||
Debt-to-EBITDA | N/A | |||||
Interest Coverage | N/A | |||||
Piotroski F-Score | 4/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -26.9 | |||||
3-Year EPS without NRI Growth Rate | -25.5 | |||||
3-Year FCF Growth Rate | 6 | |||||
3-Year Book Growth Rate | -9.3 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 66.84 | |||||
9-Day RSI | 57.69 | |||||
14-Day RSI | 54.22 | |||||
6-1 Month Momentum % | 3.53 | |||||
12-1 Month Momentum % | 37.86 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History |
---|
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 7 | |||||
Shareholder Yield % | 11.6 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Net Margin % | 95.64 | |||||
FCF Margin % | -5.44 | |||||
ROE % | 22.72 | |||||
ROA % | 20.72 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 5.01 | |||||
PE Ratio without NRI | 5.01 | |||||
Shiller PE Ratio | 15.13 | |||||
PEG Ratio | 1.93 | |||||
PS Ratio | 4.55 | |||||
PB Ratio | 0.96 | |||||
Price-to-Tangible-Book | 0.96 | |||||
EV-to-Revenue | 4.77 | |||||
EV-to-FCF | -86.71 | |||||
Price-to-Projected-FCF | 1.59 | |||||
Price-to-Graham-Number | 0.46 | |||||
FCF Yield % | -1.29 | |||||
Forward Rate of Return (Yacktman) % | 1.21 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Biotech Growth Trust (The) PLC Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil £) | 77.999 | ||
EPS (TTM) (£) | 2.07 | ||
Beta | 0.22 | ||
Volatility % | 26.95 | ||
14-Day RSI | 54.22 | ||
14-Day ATR (£) | 0.243213 | ||
20-Day SMA (£) | 10.266 | ||
12-1 Month Momentum % | 37.86 | ||
52-Week Range (£) | 7.2033 - 10.6836 | ||
Shares Outstanding (Mil) | 31.64 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Biotech Growth Trust (The) PLC Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Biotech Growth Trust (The) PLC Stock Events
Event | Date | Price(£) | ||
---|---|---|---|---|
No Event Data |
Biotech Growth Trust (The) PLC Frequently Asked Questions
What is Biotech Growth Trust (The) PLC(LSE:BIOG)'s stock price today?
When is next earnings date of Biotech Growth Trust (The) PLC(LSE:BIOG)?
Does Biotech Growth Trust (The) PLC(LSE:BIOG) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |